Clinical Trial Update: Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a pemetrexed-based combination in advanced gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Gastrointestinal Neoplasms | Phase 2 | Status: COMPLETED